Works matching IS 13570560 AND DT 2023 AND VI 40 AND IP 9

Results: 30

The mechanism of LSM2 in the progression of live hepatocellular carcinoma was analyzed based on bioinformatics.

Published in:

Medical Oncology, 2023, v. 40, n. 9, p. 1, doi. 10.1007/s12032-023-02152-0

By:

Qin, Peifang;
Huang, Haitao;
Wang, Jiahui;
Jiang, Tingting;
Zeng, Nannan;
Wang, Qi;
He, Yulin;
Zhou, Yali

Publication type:

Article

The potential of monoclonal antibodies for colorectal cancer therapy.

Published in:

Medical Oncology, 2023, v. 40, n. 9, p. 1, doi. 10.1007/s12032-023-02151-1

By:

Heidari, Fatemeh;
Madadi, Soheil;
Alizadeh, Neda;
Alimardani, Mohammad Hossein;
Safari, Armin;
Armand, Mohammad Hossein;
Pishgahzadeh, Elahe;
Soleimani, Meysam

Publication type:

Article

The Schiff base hydrazine copper(II) complexes induce apoptosis by P53 overexpression and prevent cell migration through protease-independent pathways.

Published in:

Medical Oncology, 2023, v. 40, n. 9, p. 1, doi. 10.1007/s12032-023-02150-2

By:

Asghariazar, Vahid;
Amini, Mohammad;
Pirdel, Zahra;
Fekri, Roghayeh;
Asadi, Asadollah;
Nejati-Koshki, Kazem;
Baradaran, Behzad;
Panahi, Yasin

Publication type:

Article

Mechanism of anticancer effect of gambogic acid on gastric signet ring cell carcinoma.

Published in:

Medical Oncology, 2023, v. 40, n. 9, p. 1, doi. 10.1007/s12032-023-02149-9

By:

Joha, Ziad;
Öztürk, Ayşegül;
Yulak, Fatih;
Karataş, Özhan;
Ataseven, Hilmi

Publication type:

Article

Revolutionizing cancer treatment: a comprehensive review of CAR-T cell therapy.

Published in:

Medical Oncology, 2023, v. 40, n. 9, p. 1, doi. 10.1007/s12032-023-02146-y

By:

Dabas, Preeti;
Danda, Adithi

Publication type:

Article

Hypoxia-induced PPFIA4 accelerates the progression of ovarian cancer through glucose metabolic reprogramming.

Published in:

Medical Oncology, 2023, v. 40, n. 9, p. 1, doi. 10.1007/s12032-023-02144-0

By:

Tan, Shu;
Yu, Hao;
Xu, Ye;
Zhao, Yue;
Lou, Ge

Publication type:

Article

METTL3 regulatory TROAP can regulate the progression of non-small cell lung cancer through PI3K/AKT and EMT signaling pathway.

Published in:

Medical Oncology, 2023, v. 40, n. 9, p. 1, doi. 10.1007/s12032-023-02143-1

By:

Xu, Muli;
Yu, Jiankun;
Liu, Xiaoxiao;
Jia, Wanting;
Duan, Yu;
Ma, Di;
Ma, Jiaxuan;
Lei, Wanyang;
Tai, Wenlin

Publication type:

Article

Integrative analysis of GWAS and transcriptomics data reveal key genes for non-small lung cancer.

Published in:

Medical Oncology, 2023, v. 40, n. 9, p. 1, doi. 10.1007/s12032-023-02139-x

By:

Feng, Xiangxiong

Publication type:

Article

Cancer chemoresistance and its mechanisms: Associated molecular factors and its regulatory role.

Published in:

Medical Oncology, 2023, v. 40, n. 9, p. 1, doi. 10.1007/s12032-023-02138-y

By:

Kannampuzha, Sandra;
Gopalakrishnan, Abilash Valsala

Publication type:

Article

Claudin-3 facilitates the progression and mediates the tumorigenic effects of TGF-β in glioblastoma multiforme.

Published in:

Medical Oncology, 2023, v. 40, n. 9, p. 1, doi. 10.1007/s12032-023-02136-0

By:

Sun, Zhiqiang;
Yan, Tengfeng;
Jiang, Hongxiang;
Cai, Jiayang;
Zhu, Xiwei;
Chen, Qianxue

Publication type:

Article

EGCG attenuate EGF triggered matrix abundance and migration in HPV positive and HPV negative cervical cancer cells.

Published in:

Medical Oncology, 2023, v. 40, n. 9, p. 1, doi. 10.1007/s12032-023-02135-1

By:

Sabanayagam, Rajalakshmi;
Krishnamoorthy, Sneha;
Gnanagurusamy, Jayapradha;
Muruganatham, Bharathi;
Muthusami, Sridhar

Publication type:

Article

The anticancer effects of thymol on HepG2 cell line.

Published in:

Medical Oncology, 2023, v. 40, n. 9, p. 1, doi. 10.1007/s12032-023-02134-2

By:

Altintas, Fatih;
Tunc-Ata, Melek;
Secme, Mucahit;
Kucukatay, Vural

Publication type:

Article

CRISPR screen identifies GATAD1 as a synthetic lethal target with CDK4/6 inhibitors in estrogen receptor-positive breast cancer.

Published in:

Medical Oncology, 2023, v. 40, n. 9, p. 1, doi. 10.1007/s12032-023-02133-3

By:

Liu, Wenqiang;
Zhang, Ruhua;
Yu, Xinhao;
Zhang, Yu;
Kang, Tiebang;
Liao, Dan

Publication type:

Article

HOTAIR in colorectal cancer: structure, function, and therapeutic potential.

Published in:

Medical Oncology, 2023, v. 40, n. 9, p. 1, doi. 10.1007/s12032-023-02131-5

By:

Tufail, Muhammad

Publication type:

Article

6-Methoxydihydrosanguinarine exhibits cytotoxicity and sensitizes TRAIL-induced apoptosis of hepatocellular carcinoma cells through ROS-mediated upregulation of DR5.

Published in:

Medical Oncology, 2023, v. 40, n. 9, p. 1, doi. 10.1007/s12032-023-02129-z

By:

Wang, Lin-lin;
Li, Ruo-tong;
Zang, Zi-heng;
Song, Yun-xuan;
Zhang, Yu-zhe;
Zhang, Teng-fei;
Wang, Feng-ze;
Hao, Gang-ping;
Cao, Lu

Publication type:

Article

Liquid biopsy in ovarian cancer: advantages and limitations for prognosis and diagnosis.

Published in:

Medical Oncology, 2023, v. 40, n. 9, p. 1, doi. 10.1007/s12032-023-02128-0

By:

Karimi, Farzaneh;
Azadbakht, Omid;
Veisi, Ali;
Sabaghan, Mohammad;
Owjfard, Maryam;
Kharazinejad, Ebrahim;
Dinarvand, Negar

Publication type:

Article

LHPP suppresses proliferation, migration, and invasion in hepatocellular carcinoma and pancreatic cancer by inhibiting EGFR signaling pathway.

Published in:

Medical Oncology, 2023, v. 40, n. 9, p. 1, doi. 10.1007/s12032-023-02127-1

By:

Zhu, Haitao;
Song, Chunzhuo;
Li, Junjun;
Liu, Qianfan;
Liu, Meng;
Fu, Liyue

Publication type:

Article

Small molecule heat shock protein 27 inhibitor J2 decreases ovarian cancer cell proliferation via induction of apoptotic pathways.

Published in:

Medical Oncology, 2023, v. 40, n. 9, p. 1, doi. 10.1007/s12032-023-02126-2

By:

Karademir, Dilay;
Özgür, Aykut

Publication type:

Article

Exosomal non-coding RNAs-mediated EGFR-TKIs resistance in NSCLC with EGFR mutation.

Published in:

Medical Oncology, 2023, v. 40, n. 9, p. 1, doi. 10.1007/s12032-023-02125-3

By:

Cheng, Daoan;
Wang, Banglu;
Wu, Lige;
Chen, Rui;
Zhao, Weiqing;
Fang, Cheng;
Ji, Mei

Publication type:

Article

The mechanistic insights of the antioxidant Keap1-Nrf2 pathway in oncogenesis: a deadly scenario.

Published in:

Medical Oncology, 2023, v. 40, n. 9, p. 1, doi. 10.1007/s12032-023-02124-4

By:

Mukherjee, Anirban Goutam;
Gopalakrishnan, Abilash Valsala

Publication type:

Article

CD4 T cells in chronic myeloid leukemia present MHC class II-dependent and IFN-γ-dependent cytotoxic capacity.

Published in:

Medical Oncology, 2023, v. 40, n. 9, p. 1, doi. 10.1007/s12032-023-02123-5

By:

Jiang, Yirong;
Yao, Jingwei;
Yao, Zhuoxin;
Huang, Yueting;
Li, Zhangkun;
Fan, Ziying;
Zhou, Yong;
Li, Guowei;
Li, Zhifeng;
Xu, Bing

Publication type:

Article

Anti-HSP70 alleviates cell migration and proliferation in colorectal cancer cells (CRC) by targeting CXCR4 (in vitro study).

Published in:

Medical Oncology, 2023, v. 40, n. 9, p. 1, doi. 10.1007/s12032-023-02122-6

By:

Alsaab, Hashem O.;
Almalki, Atiah H.

Publication type:

Article

SETD2 controls m6A modification of transcriptome and regulates the molecular oncogenesis of glioma.

Published in:

Medical Oncology, 2023, v. 40, n. 9, p. 1, doi. 10.1007/s12032-023-02121-7

By:

Kumari, Subhadra;
Singh, Mandakini;
Kumar, Santosh;
Muthuswamy, Srinivasan

Publication type:

Article

Advanced nano-therapeutic delivery of metformin: potential anti-cancer effect against human colon cancer cells through inhibition of GPR75 expression.

Published in:

Medical Oncology, 2023, v. 40, n. 9, p. 1, doi. 10.1007/s12032-023-02120-8

By:

Ghorbanzadeh, Fatemeh;
Jafari-Gharabaghlou, Davoud;
Dashti, Mohammad Reza;
Hashemi, Mehrdad;
Zarghami, Nosratollah

Publication type:

Article

Concomitant effects of paclitaxel and celecoxib on genes involved in apoptosis of triple-negative metastatic breast cancer cells.

Published in:

Medical Oncology, 2023, v. 40, n. 9, p. 1, doi. 10.1007/s12032-023-02119-1

By:

Hedayat, Mohaddeseh;
Khezri, Mohammad Rafi;
Jafari, Reza;
Malekinejad, Hassan;
Majidi Zolbanin, Naime

Publication type:

Article

Inhibition of IRE1 RNase activity modulates tumor cell progression and enhances the response to chemotherapy in colorectal cancer.

Published in:

Medical Oncology, 2023, v. 40, n. 9, p. 1, doi. 10.1007/s12032-023-02105-7

By:

Abbasi, Sana;
Rivand, Helia;
Eshaghi, Fatemeh;
Moosavi, Mohammad Amin;
Amanpour, Saeid;
McDermott, Michael F.;
Rahmati, Marveh

Publication type:

Article

Advances in the molecular mechanism and targeted therapy of radioactive-iodine refractory differentiated thyroid cancer.

Published in:

Medical Oncology, 2023, v. 40, n. 9, p. 1, doi. 10.1007/s12032-023-02098-3

By:

Zhang, Lu;
Li, Zhi;
Zhang, Meng;
Zou, Huangren;
Bai, Yuke;
Liu, Yanlin;
Lv, Juan;
Lv, Ling;
Liu, Pengjie;
Deng, Zhiyong;
Liu, Chao

Publication type:

Article

Current neoadjuvant therapy for operable locally advanced esophageal cancer.

Published in:

Medical Oncology, 2023, v. 40, n. 9, p. 1, doi. 10.1007/s12032-023-02097-4

By:

Yang, Wenwei;
Niu, Yaru;
Sun, Yongkun

Publication type:

Article

Analysis of the safety and effectiveness of TACE combined with targeted immunotherapy in the treatment of intermediate and advanced hepatocellular carcinoma.

Published in:

Medical Oncology, 2023, v. 40, n. 9, p. 1, doi. 10.1007/s12032-023-02082-x

By:

Liu, Wenbin;
Xie, Zhiguo;
Shen, Kefeng;
Jiang, Lizhu;
Liu, Chongyan;
Ge, Yongsheng;
Yu, Jihai;
Jia, Weidong;
Ma, Jinliang;
Chen, Hao

Publication type:

Article

Artichoke as a melanoma growth inhibitor.

Published in:

Medical Oncology, 2023, v. 40, n. 9, p. 1, doi. 10.1007/s12032-023-02077-8

By:

Mathew, Annette M.;
Deng, Zuliang;
Nelson, Christian J.;
Mayberry, Trenton G.;
Bai, Qian;
Lequio, Marco;
Fajardo, Emerson;
Xiao, Huaping;
Wakefield, Mark R.;
Fang, Yujiang

Publication type:

Article